Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that plays an essential role in both innate and acquired immunity. As an enzyme, MIF exhibits tautomerase and oxidoreductase activity. As a hormone, MIF has the ability to directly regulate the immunosuppressive actions of glucocorticoids and also affects glucose homeostasis. At the site of inflammation, MIF is able to suppress the response of macrophages to p53-mediated apoptotic signals. This connection is important in tissues suffering from chronic inflammatory disease, if MIF occurs in some tissue over a long period, it enables the accumulation of potentially oncogenic mutations. Macrophage migration inhibitory factor is expressed on high levels in tumor cells and promotes angiogenesis and cell proliferation and thereby represents direct link between inflammation and cancer. Experiments on model organism show that application of MIF-inhibitor leads to delayed tumor progression and prolonged survival of model organism. In czech.